OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 76 filers reported holding OCULAR THERAPEUTIX INC in Q1 2017. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,751,473 | -39.0% | 4,060,979 | +0.2% | 0.00% | – |
| Q2 2023 | $20,912,587 | -1.8% | 4,052,827 | +0.3% | 0.00% | -100.0% |
| Q1 2023 | $21,298,125 | +90.6% | 4,041,390 | +1.6% | 0.00% | – |
| Q4 2022 | $11,174,957 | -31.9% | 3,976,853 | +0.6% | 0.00% | – |
| Q3 2022 | $16,399,000 | +4.6% | 3,951,806 | +1.4% | 0.00% | – |
| Q2 2022 | $15,672,000 | -24.5% | 3,898,551 | -7.1% | 0.00% | – |
| Q1 2022 | $20,768,000 | -27.0% | 4,195,406 | +2.9% | 0.00% | -100.0% |
| Q4 2021 | $28,431,000 | -22.8% | 4,079,023 | +10.7% | 0.00% | 0.0% |
| Q3 2021 | $36,848,000 | -29.2% | 3,684,849 | +0.4% | 0.00% | 0.0% |
| Q2 2021 | $52,025,000 | -13.0% | 3,668,965 | +0.7% | 0.00% | -50.0% |
| Q1 2021 | $59,782,000 | -18.6% | 3,643,063 | +2.6% | 0.00% | 0.0% |
| Q4 2020 | $73,485,000 | +224.2% | 3,549,998 | +19.2% | 0.00% | +100.0% |
| Q3 2020 | $22,669,000 | -9.5% | 2,978,763 | -0.9% | 0.00% | 0.0% |
| Q2 2020 | $25,050,000 | +141.0% | 3,007,159 | +43.2% | 0.00% | – |
| Q1 2020 | $10,394,000 | +31.0% | 2,099,839 | +4.5% | 0.00% | – |
| Q4 2019 | $7,934,000 | +29.8% | 2,008,807 | -0.1% | 0.00% | – |
| Q3 2019 | $6,114,000 | -25.8% | 2,010,996 | +7.4% | 0.00% | – |
| Q2 2019 | $8,236,000 | +26.7% | 1,871,947 | +14.3% | 0.00% | – |
| Q1 2019 | $6,502,000 | +2.9% | 1,637,587 | +3.2% | 0.00% | – |
| Q4 2018 | $6,316,000 | -35.7% | 1,587,053 | +11.2% | 0.00% | – |
| Q3 2018 | $9,821,000 | +9.0% | 1,427,533 | +6.9% | 0.00% | – |
| Q2 2018 | $9,013,000 | +3.0% | 1,335,198 | -0.7% | 0.00% | – |
| Q1 2018 | $8,753,000 | +83.7% | 1,344,541 | +25.6% | 0.00% | – |
| Q4 2017 | $4,766,000 | -25.1% | 1,070,864 | +4.1% | 0.00% | – |
| Q3 2017 | $6,359,000 | -24.2% | 1,028,904 | +13.6% | 0.00% | – |
| Q2 2017 | $8,394,000 | +0.3% | 905,456 | +0.4% | 0.00% | – |
| Q1 2017 | $8,373,000 | +37.5% | 902,262 | +24.0% | 0.00% | – |
| Q4 2016 | $6,090,000 | +18.2% | 727,574 | -3.0% | 0.00% | – |
| Q3 2016 | $5,152,000 | +117.1% | 749,874 | +56.4% | 0.00% | – |
| Q2 2016 | $2,373,000 | -46.1% | 479,309 | +5.2% | 0.00% | – |
| Q1 2016 | $4,400,000 | +4.0% | 455,516 | +0.9% | 0.00% | – |
| Q4 2015 | $4,231,000 | -29.9% | 451,578 | +5.2% | 0.00% | – |
| Q3 2015 | $6,037,000 | -7.6% | 429,415 | +38.3% | 0.00% | – |
| Q2 2015 | $6,531,000 | -10.1% | 310,532 | +79.5% | 0.00% | – |
| Q1 2015 | $7,263,000 | +315.3% | 173,002 | +132.7% | 0.00% | – |
| Q4 2014 | $1,749,000 | +197.4% | 74,339 | +89.1% | 0.00% | – |
| Q3 2014 | $588,000 | – | 39,322 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 5,618,424 | $46,801,000 | 100.00% |
| Opaleye Management Inc. | 5,984,200 | $49,848,000 | 10.07% |
| DELTEC ASSET MANAGEMENT LLC | 2,330,267 | $19,411,000 | 4.06% |
| Corriente Advisors, LLC | 720,000 | $5,998,000 | 3.89% |
| Versant Venture Management, LLC | 2,215,384 | $18,454,145,000 | 2.65% |
| SV Health Investors, LLC | 312,068 | $2,600,000 | 1.80% |
| Ikarian Capital, LLC | 2,055,977 | $17,126,000 | 1.36% |
| EAM Global Investors LLC | 265,316 | $2,210,000 | 0.99% |
| EAM Investors, LLC | 346,075 | $2,883,000 | 0.64% |
| RA Capital Management | 2,727,272 | $22,718,000 | 0.44% |